Injective recently launched on @Bantr_fun. It’s not a general-purpose chain casting a wide net, but an L1 chain specifically tailored for financial scenarios. Injective’s core strengths are clear: reducing MEV interference at the protocol level and offering an on-chain order book experience that’s close to centralized matching—low slippage, fast execution, perfect for derivatives and high-frequency trading. @injective takes a Cosmos + MultiVM approach, maintaining cross-chain and performance advantages while being EVM-compatible, lowering migration barriers. The chain already has real RWA, perpetuals, and structured product transactions happening on it, and the data is starting to reflect its positioning. If you’re into DeFi with “high performance, low cost, and financial-grade experience,” Injective is a chain worth allocating some time and portfolio to observe.